Viatris Drug Patent Portfolio
Viatris owns 6 orange book drugs protected by 20 US patents with Nitrostat having the least patent protection, holding only 1 patent. And Zoloft with maximum patent protection, holding 6 patents. Given below is the list of Viatris's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7256216 | Liquid pharmaceutical compositions | 28 Nov, 2022 | Expired |
| US7256216 | Liquid pharmaceutical compositions | 28 May, 2022 | Expired |
| US6469012 | Pyrazolopyrimidinones for the treatment of impotence | 22 Apr, 2020 | Expired |
| US6727283 | Sertraline oral concentrate | 11 Apr, 2020 | Expired |
| US7067555 | Sertraline oral concentrate | 11 Apr, 2020 | Expired |
| US6469012 | Pyrazolopyrimidinones for the treatment of impotence | 22 Oct, 2019 | Expired |
| US6727283 | Sertraline oral concentrate | 11 Oct, 2019 | Expired |
| US7067555 | Sertraline oral concentrate | 11 Oct, 2019 | Expired |
| US6150366 | Ziprasidone formulations | 27 May, 2019 | Expired |
| US6245766 | Method of treating psychiatric conditions | 18 Dec, 2018 | Expired |
| US6500456 | Compressed nitroglycerin tablet and its method of manufacture | 16 Sep, 2018 | Expired |
| US6054482 | Lactam-free amino acids | 25 Oct, 2017 | Expired |
| US6054482 | Lactam-free amino acids | 25 Apr, 2017 | Expired |
| US6232304 | Inclusion complexes of aryl-heterocyclic salts | 01 Apr, 2017 | Expired |
| US6399777 | Inclusion complexes of aryl-heterocyclic salts | 01 Apr, 2017 | Expired |
| US6110918 | Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihy dro-2(1H)-indol-2-one (=ziprasidone), its preparation and its use as dopamine D2 antagonist | 26 Mar, 2017 | Expired |
| US5248699 | Sertraline polymorph | 13 Feb, 2013 | Expired |
| US5250534 | Pyrazolopyrimidinone antianginal agents | 27 Sep, 2012 | Expired |
| US5312925 | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride | 01 Sep, 2012 | Expired |
| US5248699 | Sertraline polymorph | 13 Aug, 2012 | Expired |
Latest Legal Activities on Viatris's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Viatris.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Email Notification
Critical
| 17 Aug, 2021 | US7256216 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 17 Aug, 2021 | US7256216 |
|
Correspondence Address Change
Critical
| 16 Aug, 2021 | US7256216 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 16 Jan, 2019 | US7256216 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 20 Nov, 2017 | US7067555 |
|
Recordation of Patent Grant Mailed
Critical
| 14 Aug, 2007 | US7256216 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 14 Aug, 2007 | US7256216 |
|
Issue Notification Mailed
Critical
| 25 Jul, 2007 | US7256216 |
| Dispatch to FDC | 09 Jul, 2007 | US7256216 |
| Workflow - Request for RCE - Finish | 09 Jul, 2007 | US7256216 |
|
Application Is Considered Ready for Issue
Critical
| 09 Jul, 2007 | US7256216 |
|
Issue Fee Payment Received
Critical
| 06 Jul, 2007 | US7256216 |
|
Issue Fee Payment Verified
Critical
| 06 Jul, 2007 | US7256216 |
| Mail Examiner's Amendment | 06 Apr, 2007 | US7256216 |
|
Mail Notice of Allowance
Critical
| 06 Apr, 2007 | US7256216 |
Viatris's Drug Patent Litigations
Viatris's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on May 23, 2000, against patent number US6469012. The petitioner , challenged the validity of this patent, with ELLIS et al as the respondent. Click below to track the latest information on how companies are challenging Viatris's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US6469012 | May, 2000 |
Decision
(29 Nov, 2000)
| ELLIS et al | |
Viatris's Family Patents
Viatris Drug List
Given below is the complete list of Viatris's drugs and the patents protecting them.
1. Geodon
Geodon is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6150366 | Ziprasidone formulations |
27 May, 2019
(5 years ago)
| Expired |
| US6245766 | Method of treating psychiatric conditions |
18 Dec, 2018
(5 years ago)
| Expired |
| US6232304 | Inclusion complexes of aryl-heterocyclic salts |
01 Apr, 2017
(7 years ago)
| Expired |
| US6399777 | Inclusion complexes of aryl-heterocyclic salts |
01 Apr, 2017
(7 years ago)
| Expired |
| US6110918 | Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihy dro-2(1H)-indol-2-one (=ziprasidone), its preparation and its use as dopamine D2 antagonist |
26 Mar, 2017
(7 years ago)
| Expired |
| US5312925 | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride |
01 Sep, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Geodon's drug page
2. Neurontin
Neurontin is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7256216
(Pediatric)
| Liquid pharmaceutical compositions |
28 Nov, 2022
(1 year, 11 months ago)
| Expired |
| US7256216 | Liquid pharmaceutical compositions |
28 May, 2022
(2 years ago)
| Expired |
| US6054482
(Pediatric)
| Lactam-free amino acids |
25 Oct, 2017
(7 years ago)
| Expired |
| US6054482 | Lactam-free amino acids |
25 Apr, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Neurontin's drug page
3. Nitrostat
Nitrostat is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6500456 | Compressed nitroglycerin tablet and its method of manufacture |
16 Sep, 2018
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Nitrostat's drug page
4. Revatio
Revatio is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5250534
(Pediatric)
| Pyrazolopyrimidinone antianginal agents |
27 Sep, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Revatio's drug page
5. Viagra
Viagra is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6469012
(Pediatric)
| Pyrazolopyrimidinones for the treatment of impotence |
22 Apr, 2020
(4 years ago)
| Expired |
| US6469012 | Pyrazolopyrimidinones for the treatment of impotence |
22 Oct, 2019
(5 years ago)
| Expired |
| US5250534
(Pediatric)
| Pyrazolopyrimidinone antianginal agents |
27 Sep, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Viagra's drug page
Explore Our Curated Drug Screens
6. Zoloft
Zoloft is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6727283
(Pediatric)
| Sertraline oral concentrate |
11 Apr, 2020
(4 years ago)
| Expired |
| US7067555
(Pediatric)
| Sertraline oral concentrate |
11 Apr, 2020
(4 years ago)
| Expired |
| US6727283 | Sertraline oral concentrate |
11 Oct, 2019
(5 years ago)
| Expired |
| US7067555 | Sertraline oral concentrate |
11 Oct, 2019
(5 years ago)
| Expired |
| US5248699
(Pediatric)
| Sertraline polymorph |
13 Feb, 2013
(11 years ago)
| Expired |
| US5248699 | Sertraline polymorph |
13 Aug, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zoloft's drug page